Geraldo Felício Cunha-Junior

Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial

Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes et al. · Journal of Clinical Oncology · 2024 · 42 citations · Full text

A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Òren Smaletz, Maria Del Pilar Estevez-Diz, Claudio Calazan do Carmo et al. · Gynecologic Oncology · 2015 · 24 citations

Gastrointestinal Oncology, Medicine, Platinum Resistant/refractory +9

A Rapid HPLC-ESI-MS/MS Method for Determination of Dihydrouracil/Uracil Ratio in Plasma: Evaluation of Toxicity to 5-Flurouracil in Patients With Gastrointestinal Cancer

Isabela Costa César, Geraldo Felício Cunha-Junior, Ricardo Martins Duarte Byrro et al. · Therapeutic Drug Monitoring · 2011 · 22 citations

13C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients

Geraldo Felício Cunha-Junior, Luiz Marco, Luciana Bastos‐Rodrigues et al. · Cancer Chemotherapy and Pharmacology · 2013 · 21 citations

5-Fluorouracil Toxicity, Gastrointestinal Oncology, Medicine +10

Prevalence of the DPYD variant (Y186C) in Brazilian individuals of African ancestry

Geraldo Felício Cunha-Junior, Luciana Bastos‐Rodrigues, Pedro Guimarães de Azevedo et al. · Cancer Chemotherapy and Pharmacology · 2019 · 12 citations

African Ancestry, Genetic Epidemiology, Human Polymorphism +7